Aurora supporting study of CBD as treatment for pain, depression, anxiety

An international research project led by McGill University and supported by Aurora Cannabis will examine the potential of CanniMed CBD oil to treat chronic pain and related anxiety and depression.

In an August 2018 news release, CEO Terry Booth said the study will support physicians who have started prescribing cannabis, or who are considering doing so.

“This is especially important considering the growing international momentum in legalizing medical cannabis,” he said.

CBD oil is increasingly prescribed by physicians around the world, said lead researcher Dr. Gabriella Gobbi, from McGill University’s Faculty of Medicine.

Determining how CBD oil works for pain and associated depression and anxiety will be the focus of the three-year study, which will be conducted in Canada, Italy and France.

CBD has substantial potential, said Dr. Gobbi, but “the cannabis plant and its components are yet to be fully understood.”

Determining how CBD oil works for pain and associated depression and anxiety will be the focus of the three-year study, which will be conducted in Canada, Italy and France.

“Based on our extensive experience with more than 60,000 registered Canadian patients, we believe CBD to be one of the most impactful medical compounds to become legally available to people in need of non-addictive therapies to treat pain,” said Aurora CEO Terry Booth.

 

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s